伊布替尼在人巨噬细胞吞噬过程中阻断 Btk 依赖性 NF-κB 和 NFAT 反应。
Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during phagocytosis.
机构信息
National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Medical Research Council (MRC) Centre for Medical Mycology, University of Aberdeen, Aberdeen, United Kingdom.
出版信息
Blood. 2018 Nov 1;132(18):1985-1988. doi: 10.1182/blood-2017-12-823393. Epub 2018 Jul 18.
Abstract
There is a Commentary on this article in this issue.
摘要
本期对这篇文章有评论。
相似文献
1
Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during phagocytosis.伊布替尼在人巨噬细胞吞噬过程中阻断 Btk 依赖性 NF-κB 和 NFAT 反应。
Blood. 2018 Nov 1;132(18):1985-1988. doi: 10.1182/blood-2017-12-823393. Epub 2018 Jul 18.
2
Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus.吞噬作用依赖的TLR9-BTK-钙调神经磷酸酶-NFAT途径激活协调对烟曲霉的固有免疫。
EMBO Mol Med. 2015 Mar;7(3):240-58. doi: 10.15252/emmm.201404556.
3
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia.BTK 抑制会损害慢性淋巴细胞白血病患者对真菌感染的固有免疫反应。
Front Immunol. 2020 Aug 28;11:2158. doi: 10.3389/fimmu.2020.02158. eCollection 2020.
4
BTK inhibitor-induced defects in human neutrophil effector activity against Aspergillus fumigatus are restored by TNF-α.BTK 抑制剂诱导的人类中性粒细胞对烟曲霉效应器活性缺陷可被 TNF-α 恢复。
JCI Insight. 2024 May 7;9(12):e176162. doi: 10.1172/jci.insight.176162.
5
Second generation BTK inhibitors impair the anti-fungal response of macrophages and neutrophils.第二代布鲁顿酪氨酸激酶（BTK）抑制剂会损害巨噬细胞和中性粒细胞的抗真菌反应。
Am J Hematol. 2020 Jul;95(7):E174-E178. doi: 10.1002/ajh.25816. Epub 2020 Apr 29.
6
Ibrutinib and a Btk-targeted risk.依鲁替尼与Btk靶向风险。
Blood. 2018 Nov 1;132(18):1869-1870. doi: 10.1182/blood-2018-08-865659.
7
Zanubrutinib for the treatment of Waldenström Macroglobulinemia.泽布替尼用于治疗华氏巨球蛋白血症。
Expert Rev Hematol. 2020 Dec;13(12):1303-1310. doi: 10.1080/17474086.2020.1851184. Epub 2020 Dec 9.
8
Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages.烟曲霉刺激巨噬细胞后 NF-κB 的激活和呼吸爆发。
Immunobiology. 2014 Jan;219(1):25-36. doi: 10.1016/j.imbio.2013.06.013. Epub 2013 Jul 4.
9
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.依鲁替尼对原发性中枢神经系统淋巴瘤中B细胞受体信号传导的抑制作用
Cancer Cell. 2017 Jun 12;31(6):833-843.e5. doi: 10.1016/j.ccell.2017.04.012. Epub 2017 May 25.
10
Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors.布鲁顿酪氨酸激酶抑制剂的皮肤毒性。
Am J Clin Dermatol. 2020 Dec;21(6):799-812. doi: 10.1007/s40257-020-00535-x.
引用本文的文献
1
Pulmonary Coccidioidomycosis Occurring in a Patient Treated With Acalabrutinib for Chronic Lymphocytic Leukemia.一名接受阿卡拉布替尼治疗慢性淋巴细胞白血病的患者发生肺球孢子菌病。
Cureus. 2025 Apr 26;17(4):e83026. doi: 10.7759/cureus.83026. eCollection 2025 Apr.
2
Functional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets.功能性蛋白变体组反卷积揭示了伊布替尼脱靶效应的更广泛范围。
Nat Commun. 2025 Feb 25;16(1):1948. doi: 10.1038/s41467-024-54654-8.
3
Recent developments in research: diversity, drugs, and disease.研究的最新进展：多样性、药物与疾病。
Microbiol Mol Biol Rev. 2025 Mar 27;89(1):e0001123. doi: 10.1128/mmbr.00011-23. Epub 2025 Feb 10.
4
BTK and YKL-40 Levels and Their Association with Acute AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.BTK和YKL-40水平及其与急性水通道蛋白4-IgG阳性视神经脊髓炎谱系障碍的关联。
Mol Neurobiol. 2025 Apr;62(4):4785-4801. doi: 10.1007/s12035-024-04588-5. Epub 2024 Nov 1.
5
Risk of Invasive Fungal Infections in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score-Matched Analysis.接受布鲁顿酪氨酸激酶抑制剂治疗的慢性淋巴细胞白血病患者发生侵袭性真菌感染的风险：一项病例对照倾向评分匹配分析
Open Forum Infect Dis. 2024 Feb 28;11(6):ofae115. doi: 10.1093/ofid/ofae115. eCollection 2024 Jun.
6
BTK inhibitor-induced defects in human neutrophil effector activity against Aspergillus fumigatus are restored by TNF-α.BTK 抑制剂诱导的人类中性粒细胞对烟曲霉效应器活性缺陷可被 TNF-α 恢复。
JCI Insight. 2024 May 7;9(12):e176162. doi: 10.1172/jci.insight.176162.
7
BTK drives neutrophil activation for sterilizing antifungal immunity.布鲁顿酪氨酸激酶（BTK）驱动中性粒细胞活化以实现抗真菌免疫清除。
J Clin Invest. 2024 May 2;134(12):e176142. doi: 10.1172/JCI176142.
8
Community-acquired pneumonia: a US perspective on the guideline gap.社区获得性肺炎：美国视角下的指南差距。
J Antimicrob Chemother. 2024 May 2;79(5):959-961. doi: 10.1093/jac/dkae050.
9
Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia.布鲁顿酪氨酸激酶抑制：治疗华氏巨球蛋白血症的有效策略。
Curr Hematol Malig Rep. 2024 Jun;19(3):120-137. doi: 10.1007/s11899-024-00731-0. Epub 2024 Mar 27.
10
New anticancer therapeutics impact fungal pathobiology, infection dynamics, and outcome.新型抗癌疗法会影响真菌病理生物学、感染动态及治疗结果。
PLoS Pathog. 2023 Dec 21;19(12):e1011845. doi: 10.1371/journal.ppat.1011845. eCollection 2023 Dec.
本文引用的文献
1
Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.行动呼吁：伊布替尼和其他靶向免疫信号通路的小分子激酶抑制剂相关的侵袭性真菌感染。
Clin Infect Dis. 2018 Jan 6;66(1):140-148. doi: 10.1093/cid/cix687.
2
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.依鲁替尼对原发性中枢神经系统淋巴瘤中B细胞受体信号传导的抑制作用
Cancer Cell. 2017 Jun 12;31(6):833-843.e5. doi: 10.1016/j.ccell.2017.04.012. Epub 2017 May 25.
3
Calcineurin Orchestrates Lateral Transfer of Aspergillus fumigatus during Macrophage Cell Death.钙调神经磷酸酶在巨噬细胞死亡过程中调控烟曲霉的横向转移。
Am J Respir Crit Care Med. 2016 Nov 1;194(9):1127-1139. doi: 10.1164/rccm.201601-0070OC.
4
Small-molecule kinase inhibitors: an analysis of FDA-approved drugs.小分子激酶抑制剂：FDA 批准药物分析。
Drug Discov Today. 2016 Jan;21(1):5-10. doi: 10.1016/j.drudis.2015.07.008. Epub 2015 Jul 23.
5
Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury.布鲁顿酪氨酸激酶对于NLRP3炎性小体激活至关重要，并导致缺血性脑损伤。
Nat Commun. 2015 Jun 10;6:7360. doi: 10.1038/ncomms8360.
6
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK.布鲁顿酪氨酸激酶（BTK）和白细胞介素-2诱导激酶（ITK）的抑制剂依鲁替尼可增强检查点阻断的治疗性抗肿瘤免疫。
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):E966-72. doi: 10.1073/pnas.1500712112. Epub 2015 Feb 17.
7
Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus.吞噬作用依赖的TLR9-BTK-钙调神经磷酸酶-NFAT途径激活协调对烟曲霉的固有免疫。
EMBO Mol Med. 2015 Mar;7(3):240-58. doi: 10.15252/emmm.201404556.
8
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib.停用依鲁替尼后慢性淋巴细胞白血病患者的预后
Blood. 2015 Mar 26;125(13):2062-7. doi: 10.1182/blood-2014-09-603670. Epub 2015 Jan 8.
9
The non-receptor tyrosine kinase Tec controls assembly and activity of the noncanonical caspase-8 inflammasome.非受体酪氨酸激酶Tec控制非经典半胱天冬酶-8炎性小体的组装和活性。
PLoS Pathog. 2014 Dec 4;10(12):e1004525. doi: 10.1371/journal.ppat.1004525. eCollection 2014 Dec.
10
Bruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib.布鲁顿酪氨酸激酶抑制剂及其在治疗 B 细胞恶性肿瘤中的临床潜力：以伊布替尼为例。
Ther Adv Hematol. 2014 Aug;5(4):121-33. doi: 10.1177/2040620714539906.
Zotero 插件